Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course

Acta Anaesthesiologica Scandinavica

Volumn 53, Issue 6, 2009, Pages 717-723

  Ahlbeck, K ^a,c   Fredriksson, K ^b   Rooyackers, O ^b   Mabck G ^c   Remahl, S ^c   Ansved, T ^c   Eriksson, L ^a   Radell, P ^a  

^a Section for Anaesthesiology and Intensive Care Medicine   (Sweden)

^b Department of Clinical Science Intervention and Technology ^*  (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CITRATE SYNTHASE; HYDROCORTISONE; STEROID; SUPEROXIDE DISMUTASE; SUXAMETHONIUM;

ADULT; AGED; AREFLEXIA; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE COURSE; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; HYPOREFLEXIA; INTENSIVE CARE UNIT; LABORATORY TEST; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; OXIDATIVE STRESS; POLYNEUROPATHY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEPSIS; SINGLE DRUG DOSE; TENDON REFLEX;

ADULT; AGED; BIOPSY; CRITICAL ILLNESS; ELECTROMYOGRAPHY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MUSCULAR DISEASES; NEUROLOGIC EXAMINATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; POLYNEUROPATHIES; RESPIRATION, ARTIFICIAL;

EID: 67149128188     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2009.01952.x     Document Type: Article

References (39)

1. De Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op De Coul DA, Van Der Meche FG. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001 29 : 2281 6.
2. Hund EF, Fogel W, Krieger D, Degeorgia M, Hacke W. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 1996 24 : 1328 33.
3. Leijten FS, De Weerd AW. Critical illness polyneuropathy. A review of the literature, definition and pathophysiology. Clin Neurol Neurosurg 1994 96 : 10 9.
4. Van Mook WN, Hulsewe-Evers RP. Critical illness polyneuropathy. Curr Opin Crit Care 2002 8 : 302 10.
5. Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, Mcvey AL. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994 17 : 647 54.
6. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991 14 : 1131 9.
7. Douglass JA, Tuxen DV, Horne M, Scheinkestel CD, Weinmann M, Czarny D, Bowes G. Myopathy in severe asthma. Am Rev Respir Dis 1992 146 : 517 9.
8. Helliwell TR, Coakley JH, Wagenmakers AJ, Griffiths RD, Campbell IT, Green CJ, Mcclelland P, Bone JM. Necrotizing myopathy in critically-ill patients. J Pathol 1991 164 : 307 14.
9. Hirano M, Ott BR, Raps EC, Minetti C, Lennihan L, Libbey NP, Bonilla E, Hays AP. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992 42 : 2082 7.
10. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996 40 : 645 54.
11. Bird SJ. Diagnosis and management of critical illness polyneuropathy and critical illness myopathy. Curr Treat Options Neurol 2007 9 : 85 92. (Pubitemid 46359164)
12. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007 33 : 1876 91.
13. Witt NJ, Zochodne DW, Bolton CF, Grand'maison F, Wells G, Young GB, Sibbald WJ. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991 99 : 176 84.
14. Boekstegers P, Weidenhofer S, Pilz G, Werdan K. Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock. Infection 1991 19 : 317 23.
15. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002 360 : 219 23.
16. Fredriksson K, Hammarqvist F, Strigard K, Hultenby K, Ljungqvist O, Wernerman J, Rooyackers O. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab 2006 291 : E1044 50.
17. Gasparetto A, Corbucci GG, Candiani A, Gohil K, Edwards RH. Effect of tissue hypoxia and septic shock on human skeletal muscle mitochondria. Lancet 1983 2 : 1486.
18. Rooyackers OE, Kersten AH, Wagenmakers AJ. Mitochondrial protein content and in vivo synthesis rates in skeletal muscle from critically ill rats. Clin Sci (London) 1996 91 : 475 81.
19. Schumer W, Erve PR, Obernolte RP. Endotoxemic effect on cardiac and skeletal muscle mitochondria. Surg Gynecol Obstet 1971 133 : 433 6.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985 13 : 818 29.
21. Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45. London : Her Majesty's Stationary Office, 1976.
22. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP-SCCM Consensus Conference Committee. American College of Chest Physicians-Society of Critical Care Medicine. Chest 1992 101 : 1644 55.
23. Dubowitz V. Muscle biopsy: a practical approach. London : Bailliere-Tindall, 1985.
24. Lane RJM. Handbook of muscle disease. New York : Marcel Dekker, 1996.
25. Brooke MH, Kaiser KK. Muscle fiber types: how many and what kind? Arch Neurol 1970 23 : 369 79.
26. Stibler H, Edstrom L, Ahlbeck K, Remahl S, Ansved T. Electrophoretic determination of the myosin-actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med 2003 29 : 1515 27.
27. Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. New York : Oxford University Press, Inc., 2001.
28. Tepper M, Rakic S, Haas JA, Woittiez AJ. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 2000 56 : 211 4.
29. Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000 26 : 1360 3.
30. Sancho J, Servera E. Noninvasive ventilation for patients with neuromuscular disease and acute respiratory failure. Chest 2008 133 : 314 5 author reply 15.
31. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations: pituitary basophilism. Bull Johns Hopkins Hosp 1932 50 : 137 95.
32. Muller R, Kugelberg E. Myopathy in Cushing's syndrome. J Neurol Neurosurg Psychiatry 1959 22 : 314 9.
33. Askari A, Vignos PJ Jr., Moskowitz RW. Steroid myopathy in connective tissue disease. Am J Med 1976 61 : 485 92.
34. Braunstein PW Jr., Degirolami U. Experimental corticosteroid myopathy. Acta Neuropathol 1981 55 : 167 72.
35. Norman H, Kandala K, Kolluri R, Zackrisson H, Nordquist J, Walther S, Eriksson LI, Larsson L. A porcine model of acute quadriplegic myopathy: a feasibility study. Acta Anaesthesiol Scand 2006 50 : 1058 67.
36. Ginz HF, Iaizzo PA, Urwyler A, Pargger H. Use of non-invasive-stimulated muscle force assessment in long-term critically ill patients: a future standard in the intensive care unit? Acta Anaesthesiol Scand 2008 52 : 20 7.
37. Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz NJ. Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 1996 22 : 849 55.
38. De Jonghe B, Cook D, Sharshar T, Lefaucheur JP, Carlet J, Outin H. Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d'Etude sur les Neuromyopathies En Reanimation. Intensive Care Med 1998 24 : 1242 50.
39. Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006 67 : 1421 5.